Matthew Siegel
Investor
Matthew is an accomplished Entrepreneur, Senior Executive, and Angel Investor with more than 30 years of success within investment management and has worked with clients spanning nearly every industry. His areas of expertise include Commodities, trading, options, business development, M&A, strategy, risk assessment, and private investments.
Throughout his career Matthew has held leadership positions with; Paulstar Corp., MAS, Inc, Siegel family investments, LLC, and General Mills Inc.
Matthew serves on the Board of Directors for OssiFi Therapeutics, OssiFi OMAB, and the JCRB. Matthew also served as the Vice Chair of the Kansas City Board of Trade. Matthew has a B.S. in Agronomy with a minor in Agricultural Economics from Iowa State University.
Return to Our Team here.
Corporate Development
Privately held company. Since its inception, it has been capitalized using convertible notes, non-dilutive grants, and equity.
Professionals
OssiFi is developing best in class sclerostin small molecule inhibitors to take advantage of new opportunities to develop safer, more effective bone building therapies.
Distribution List
Sign up to keep updated on OssiFi news.
Careers
OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation.
ABOUT US
OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.